Hints and tips:
Related Special Reports
Related Topics
...Although payment reporting standards differ between countries, Soriot receives higher pay than totals reported for other European pharmaceutical executives but is paid slightly less than some US peers....
...Soriot already earns more than bosses of larger European pharmaceutical companies....
...Soriot is already among the highest-paid bosses in the FTSE with a £16.9mn deal in 2023 and takes home more than the chiefs of European pharmaceutical rivals....
State aid package worth tens of millions of pounds expected as part of any agreement
...The pharmaceutical industry is also increasingly interested in the polygenic risk scores, which they can use to discover new targets for drugs, select patients for clinical trials, and expand the use of...
...Miels said that the pharmaceutical company has since “rebuilt” its business in China....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...In February, the UK pharmaceuticals company hit a long-term sales target that once seemed out of reach....
...Like many European pharmaceutical companies, it makes a large proportion of sales in the US....
Annual earnings at Anglo-Swedish pharma group miss expectations but revenues rise to $45.8bn
...Dato-DXd, which has been developed with Japanese pharmaceutical company Daiichi Sankyo, and Enhertu, another AstraZeneca treatment, are considered by analysts to be potentially high-earning drugs....
...Index complier FTSE Russell confirmed the move on Wednesday afternoon, adding that technical products provider Diploma, Hikma Pharmaceuticals and Dechra Pharmaceuticals would also join the blue-chip index...
Strong uptake of UK pharma group’s vaccine has helped to ease fears of a patent cliff
Virginia-based drugmaker says switch would attract more US investors
...The tribunal ruled that the largest company in the FTSE 100 discriminated against James Muir — a leading scientist who had been developing the pharmaceutical company’s drug, Truqap — on the basis of a disability...
Group plans to refocus on 30 core brands
...Children in Cameroon will begin receiving malaria vaccines as part of a rollout of the medicine developed by UK pharmaceutical company GSK in up to 12 countries across sub-Saharan Africa....
Forerunners of pharma company tested vaccines at notorious institutions for decades
...The deal comes as pharmaceutical companies are gathered in San Francisco for an annual industry conference this week, with GSK rivals Johnson & Johnson striking a $2bn deal to acquire an oncology biotech...
...But, like rival large pharmaceutical companies, it has mainly signed licensing agreements for particular drugs, rather than outright acquisitions....
Anglo-Swedish pharma group agrees to buy Seattle-based biotech Icosavax
...In second place, with five promotions and demotions, is Hikma Pharmaceuticals....
Vaccine recipient claims he suffered side effect of severe blood clot
...The estate already houses a number of organisations in the sector, including Genomics England, Barts Health NHS Trust and the General Pharmaceutical Council....
...The Anglo-Swedish drugmaker has partnered with Daiichi Sankyo, the Japanese pharmaceutical company, on the development of two key “antibody drug conjugates”, which use antibodies to deliver a chemotherapy...
International Edition